4,4,4',4',6,6,6',6'-Octamethyl-2,2'-bi(1,3,2-dioxaborinane), 95.0%, 10g

4,5,6,7-Tetrachloro-2-methylisoindoline-1,3-dione, 97%, 100mg

Isoquinoline-6-carbaldehyde, 95.0%, 5g

2,5-DIMETHOXYCINNAMIC ACID, 95%, 10g

2,2,2-Trifluoro-1-(4-nitrophenyl)ethanone, 95.0%, 250mg

3-(2-METHYL-PYRIDIN-3-YL)-PROPIONIC ACID, 95.0%, 100mg

Ethyl 5-(4-methylphenyl)-5-oxovalerate, 97.0%, 25g

1-[(3aS,8aS)-tetrahydro-2,2-diMethyl-4,4,8,8-tetraphenyl-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl]- Piperidine, 98%, 100mg

GC capillary column ROTI®Cap-624, 50 m, 0.25 mm, 1.40 µm, 1 Piece(s)

4,5,6,7-Tetrahydrobenzo[b]thiophene-2-carboxylic acid, 98.0%, 5g

3-Chloro-5-fluorobenzoic acid, 97.0%, 1g

N-METHYLCYCLOPROPANECARBOXAMIDE, 95.0%, 250mg

Ethyl propionate, 99.0%, 500g